Please Wait...

Ira Goodman

Translation skills

Main profile

Ira Goodman
Ira Goodman, MD
Key Opinion Leader

A board certified neurologist specializing in Alzheimer's disease, Parkinson's disease, dementia, and other neurodegenerative disorders, Dr. Goodman has worked on over 100 clinical trials. His investigations have covered all phases of clinical research and are highlighted by numerous groundbreaking trials in Alzheimer's disease. He is extensively published in the field of neurology, most particularly in the area of biomarkers in Alzheimer's disease.

In addition to his work as a Principal Investigator, Dr. Goodman serves as the Medical Director of the Compass Clinic, a private neurology practice within the Bioclinica Research Network.

He currently serves as an Associate Professor of Neurology at the University of Central Florida, College of Medicine and as an Associate Clinical Professor of Neurology at the University of Florida, College of Medicine.

Before joining the Bioclinica Research Network, Dr. Goodman led neurology at Orlando Regional Medical Center and founded the state-funded Memory Disorder Center of Central Florida, where he has served as director for the past 15 years.

Dr. Goodman has been named "Top Neurologist in Central Florida" for 14 consecutive years by Orlando Magazine, was named "Top Neurologist in the Country" by US News & World Report, and is sought after and quoted by The Wall Street Journal as a leading authority on Alzheimer's disease.

Dr. Goodman earned his medical degree at the Medical College of Pennsylvania.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Still time to catch up on summer reading on recent developments in #Alzheimer's Disease Fluid Biomarkers here int t… https://t.co/kyQmz7FxlN
bioclinica (2 days ago)
Our clients have substantial success w #eSource, some spanning well over a decade. Still other organizations remain… https://t.co/UwVs6ajPp4
bioclinica (3 days ago)
Our clients have substantial success w #eSource, some spanning well over a decade. Still some in the industry remai… https://t.co/ASuUvN6xb9
bioclinica (5 days ago)
RT @RfwrightLSL: When Do You Think #BYOD (Bring Your Own Device) Will Become Widely Used To Capture PRO Data In #Clinical #Research? https:…
bioclinica (2 weeks ago)
ICYMI: Our V.P./Head of Neuroscience & Cardiovascular Svcs., Dr. Joyce Suhy, talks about challenges in determining… https://t.co/Lns6B3VPPN
bioclinica (2 weeks ago)
RT @FCR_News_Today: FDA Issues New Guides on Use of Electronic Health Information in #ClinicalTrials. #ClinicalResearch https://t.co/j8LHV2…
bioclinica (2 weeks ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen